Colgate-Palmolive
CL | NYSE
$86.26
-$1.21 (-1.38%)
At close: Sep 21, 2026, 4:00 PM ET
$86.48
+$0.22 (+0.26%)
After-hours:
Sep 21, 2026, 7:43 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 20.38B | 20.1B | 19.46B | 17.97B | 17.42B | 16.47B |
Cost of Revenue | 8.13B | 8B | 8.21B | 7.82B | 7.13B | 6.54B |
Gross Profit | 12.25B | 12.11B | 11.25B | 10.15B | 10.29B | 9.93B |
Operating Income | 4.35B | 4.38B | 4.13B | 3.59B | 3.89B | 3.91B |
Interest Income | 75M | 67M | 55M | 14M | 17M | 19M |
Pretax Income | 3.06B | 3.96B | 3.39B | 2.66B | 3.09B | 3.65B |
Net Income | 2.13B | 2.89B | 2.3B | 1.79B | 2.17B | 2.7B |
Selling & General & Admin | 7.9B | 7.81B | 6.78B | 6.25B | 6.1B | 5.73B |
Research & Development | n/a | 355M | 343M | 320M | 307M | 290M |
Other Expenses | n/a | -442M | n/a | n/a | n/a | n/a |
Operating Expenses | 7.9B | 7.72B | 7.12B | 6.57B | 6.41B | 6.02B |
Interest Expense | 267M | 292M | 287M | 167M | 117M | 160M |
Selling & Marketing Expenses | n/a | 2.72B | n/a | n/a | n/a | n/a |
Cost & Expenses | 16.03B | 15.72B | 15.33B | 14.38B | 13.54B | 12.56B |
Income Tax Expense | 798M | 907M | 937M | 693M | 749M | 787M |
Shares Outstanding (Basic) | 808.7M | 817.7M | 827.4M | 836.4M | 845M | 856.8M |
Shares Outstanding (Diluted) | 811.1M | 822.5M | 829.2M | 838.8M | 848.3M | 859.3M |
EPS (Basic) | 2.64 | 3.53 | 2.78 | 2.13 | 2.56 | 3.15 |
EPS (Diluted) | 2.63 | 3.51 | 2.77 | 2.13 | 2.55 | 3.14 |
EBITDA | 3.96B | 4.85B | 4.25B | 3.37B | 3.76B | 4.35B |
EBIT | 3.33B | 4.25B | 3.68B | 2.83B | 3.2B | 3.81B |
Depreciation & Amortization | 630M | 605M | 567M | 545M | 556M | 539M |
Add to Watchlist
Select watchlists to add or remove CL